Compare DexCom, Inc. (DXCM) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs ZIM Integrated Shipping Services Ltd — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while ZIM Integrated Shipping Services Ltd trades at $29.99 (market cap $3.65B). The key difference: DexCom, Inc. is far larger — about 8.7× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| DXCM | ZIM | |
|---|---|---|
Market Cap | $31.86B | $3.65B |
Volume | 3,607,070 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $92.34 | $30.51 |
52-Week Low | $54.84 | $12.44 |
Typical Hold Time | 62 Days | 27 Days |
Enterprise Value | $31.32B | $7.32B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
ZIM trades at $30.26, up 0.9% on the day and near its 52-week high of $30.96. The technical outlook is bullish based on moving averages, though oscillators are neutral. Fundamentally, Q2 2026 earnings beat estimates with EPS of $0.53 versus an expected loss, driven by higher freight rates and volumes. Revenue for 2026 is projected at $6.4B with a net income margin of 2.15%. The stock appears undervalued with a P/S of 0.57 and P/B of 0.94. Recent news highlights a pending $35 per share acquisition offer from Hapag-Lloyd, subject to Israeli government approval.
The investment outlook is mixed. The potential acquisition at a premium offers upside, and strong transpacific rates support earnings. However, analyst sentiment is cautious with no buy ratings, and net cash flow remains negative. Key risks include deal uncertainty, geopolitical factors, and volatile shipping rates. The stock presents a speculative opportunity tied to merger prospects and cyclical industry conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
